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1. Introduction 
QMRA, quantitative magnetic resonance angiography, is currently the only non-invasive 
modality with which to quantify blood flow in the human vasculature. Dr. Fady Charbel, a 
vascular neurosurgeon at the University of Chicago, spearheaded the application of this 
technology to the cerebrovascular system. Knowledge and experience garnered through 
years of research by Dr. Charbel and others on computer modeling and circulatory fluid 
dynamics culminated in the development of computer software referred to as non-invasive 
optimal vessel analysis (NOVA) (Zhao et al., 2000). QMRA uses traditional time-of-flight 
and phase-contrast MRI to visualize extracranial and intracranial vascular anatomy and 
measure volumetric blood flow. VasSol Inc., through which the software is now 
commercially available, acquired pre-market FDA approval for the technology in 2002. 
NOVA is currently in use at 24 centers throughout this country and in only six centers 
outside the United States. Just a few publications have appeared using this technology. 
Reports on NOVA have been published demonstrating its use as a decision-making tool for 
patients with vertebrobasilar ischemia (Amin-Hanjani et al., 2005), as a means to document 
vascular bypass patency (Amin-Hanjani et al., 2007), as a means to evaluate in-stent stenosis 
after intracranial stent placement (Prabhakaran et al., 2009), as a measure of successful 
embolization of Vein of Galen malformations (Langer et al., 2006b), as a means to determine 
whether patients will tolerate carotid occlusion (Charbel et al., 2004), as a means to study 
vertebrobasilar flow in patients with subclavian steal syndrome (Bauer et al., 2008), as a 
means to quantify blood volume from leptomeningeal collaterals in patients with anterior 
circulation stenoses (Ruland et al., 2008), as a means to quantify carotid blood flow changes 
after carotid endarterectomy and carotid angioplasty and stenting for atherosclerotic disease 
(Ghogawala et al., 2008) and as a means to understand a difficult case of hemispheric 
ischemia and subclavian stenosis and plan treatment (Langer et al., 2006a). Most recently, 
we published on the reproducible use of NOVA to demonstrate arterial waveform changes 
both before and after a neurovascular intervention in ten patients (Brisman et al., 2011).  
This chapter documents the use of NOVA for a cohort of 19 patients with a variety of 
cerebrovascular diseases. Nineteen cases treated over an 18-month period are discussed, 10 
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of whom had arterial waveform data previously reported (Brisman et al., 2011). The 
benefits, limits and potential pitfalls of the technology are evaluated.  
2. Patients and methods 
All NOVA procedures were performed on a 1.5 Tesla MRI. NOVA can study the 
intracranial, cervical and/or aortic vasculature, as well as the vascular system of other body 
parts such as the kidneys. Gadolinium is not required for NOVA, but would be given if it 
were deemed worthwhile for the MRA (which is always obtained as part of the NOVA test) 
or if an additional brain or spine MRI was performed that required it. On average, NOVA 
added 25-40 minutes to the MRI scan time, depending on technical experience and 
complexity of the case. 
Retrospective review of all NOVA studies was approved by the IRB of the treating 
institution. Each NOVA was given one of three scores by the authors based on its perceived 
clinical utility as follows: CD (Clinical Decision-making) = NOVA results altered decision-
making for the patient in a substantial way. This generally meant that a procedure was or 
was not offered to the patient based on NOVA results or that the type of procedure 
performed was decided based on NOVA; HP (Hypothesized Pathophysiology) = NOVA 
results were consistent with the clinical picture such that the authors felt that NOVA further 
supported the management strategy but the results did not alter treatment. This score also 
was given in situations where the NOVA findings had no bearing on decision-making but 
reflected what one would expect from the disease entity, i.e. a brain AVM showing 
increased flow in feeding arteries and draining veins, or an area of significant stenosis 
showing decreased flow; NUD (No Useful Data) = NOVA yielded data that was confusing 
or contrary to what is generally understood about a particular disease entity. The NUD 
score was also given in instances where there was no apparent alteration of flow that may 
have simply reflected the disease entity considered, i.e. NOVA results on a patient with a 
small intracranial aneurysm.  
Note was also made of results for blood vessels separate from the region of interest that 
were abnormal with no ready explanation, which for simplicity we will call “false positive” 
data. Abnormal values were grouped into those that were 10-50 cc/min higher or lower 
than the expected normal baseline values and those that were 50 cc/min higher or lower 
than the expected normal values (Table 1). The distinction between “false positive” data, 
and data that would result in a NUD designation is that “false positive” values were 
typically recorded for blood vessels distinct from the region of pathologic interest. A patient 
with HP data for the region of interest, for example, might also have values for vessels that 
the were felt to be unrelated in a straightforward fashion to the region of interest and 
therefore while these specific values might be hard to interpret they did not necessarily 
affect the overall designation of the study. 
3. Results 
Twenty-Nine NOVA studies were performed over an 18 month period on 19 patients for a 
wide variety of cerebrovascular pathologies including vasospasm after aneurysmal SAH (1 
patient), gamma knife radiosurgery of brain AVMs (3), carotid stenosis from fibromuscular 
dysplasia (2), high-flow (1) and low-flow bypass (1), angioplasty and stenting using the 
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Wingspan Stent (2), Neuroform-stenting and coiling of aneurysms (2), and conservatively 
treated atherosclerotic intracranial disease (2) (Table 1). Two patients with non-vascular 
pathology were also studied. In 13/19 (68%) patients an intervention was performed after 
the initial NOVA study; of those 10/13 (77%) had post-procedure repeat NOVA studies. 
NOVA was found to be CD in 4/19 patients (21%), HP in 12/19 (63%) and NUD in 3/19 
(16%). The test was CD or HP in 10/10 cases in which NOVA was performed before and 
after an intervention. False positive values were found in 12/29 (41%) studies, nine of which 
had an abnormal value 50 cc/min less than or greater than normal. 
 
Age/Sex Pathology QMRA BaL Intervention QMRA PP 
QMRA 
Score 
False 
Positive 
61F Paraclinoid 
Aneurysm 
Normal Stent/Coil NA NUD BA84, 
LMCA99 
63F SAH/Acomm 
Aneurysm
RMCA62 Clipping “Triple 
H”
RMCA119 HP  
56F Hydocephalus
Colloid Cyst
Normal VPS NA NUD  
72M Carotid 
Stenosis
RICA117 CAS NA HP  
66F Basilar 
Aneurysm 
Subclavian 
Stenosis 
LVA-30, 
BA74, 
LPCA29, 
RPCA40 
Subclavian 
Angioplasty/Stent 
Aneurysm 
Stent/Coil 
LVA122, BA145, 
LPCA56, 
RPCA77 
CD LCCA253 
RCCA220 
LACA33 
LMCA91 
79F Basilar Stenosis BA40 None NA HP LVA31 
RVA68 
62M 
(Case 2) 
LCCA 
Occlusion 
LMCA65, 
LCCA0 
Subclavian/Carotid 
Bypass 
Bypass 242, 
LICA164, 
LMCA 111 
HP RCCA158 
RCCA243 
BA143 
49F LICA FMD LCCA146, 
LICA63, 
RICA443, 
LACA-99,  
RACA188, 
LPCA112
None NA HP  
39F 
(Case 1) 
R Temporal 
AVM 
RCCA448, 
RPCA130, 
LTS 215, RTS 
871, STS 542, 
BVR 405
GKR RCCA397 
SSS 343, LTS 
487, RTS 661, 
STS 487, BVR 
341 
HP  
65F Basilar Stenosis BA18 None NA HP  
65F Subfrontal 
AVM 
LTS 132, RTS 
573, STS 117, 
SAS 510
GKR RCCA 271, SSS 
402, LTS 102, 
RTS 354, STS 83
HP  
36F 
(Case 5) 
RICA FMD RCCA160, 
RICA74
RCAS RICA 212, BA 
143 
HP RACA29 
LVA197 
31F R Parietal 
AVM 
RMCA741, 
LACA238, 
SSS 724, STS 
81, RTS 656, 
LTS 325 
GKR RMCA541, 
RICA457, 
LICA500, 
LACA249, 
RTS 605, LTS 
424, SSS 738, 
STS 101, DV 30
HP  
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Age/Sex Pathology QMRA BaL Intervention QMRA PP 
QMRA 
Score 
False 
Positive 
70F Meningioma 
Resection 
LICA154, 
RICA132 
  NUD BA114 
RPCA36 
63F R TS Dural 
Fistula 
Normal None NA NUD LICA168 
RICA142 
BA122 
54F RICA 
Occlusion 
RICA0, 
RCCA115, 
RMCA44, 
LACA-195, 
RACA-45, 
RPCA140, 
LMCA 206
STA/MCA Bypass RMCA27, 
RCCA146, 
LMCA 249, 
LACA-261, 
RACA-18, 
RPCA 108 
(Normal) 
HP LVA206 
LACA-261 
52M 
(Case 3) 
Multiple Sx. 
BL Vertebral 
Stenoses 
LVA26, 
RVA58, 
BA5 
VA/Stent BA140, LVA 
179, RVA26 
CD RCCA288, 
LICA165, 
LACA40 
55M SAH/Pcomm 
Aneurysm 
NA Stent/Coil Normal (X mos.) NUD  
69M 
(Case 4) 
Sx. Right 
Vertebral 
Stenosis 
RVA26, 
(BA157) 
VA/Stent RVA 73, (BA 
166) 
HD RACA41, 
RCCA287, 
LVA189, 
LACA-
306, 
LICA366, 
LPCA115 
Table 1. QMRA Cases: Key: False Positive = the results of NOVA had no simple explanation 
based on the pathology and could not be explained by the authors. Note: in instances where 
there was False Positives and two NOVA studies had been performed, one before and one 
after an intervention, boldface was used to clarify which study the data was from. BaL = 
baseline, PP = postprocedureless, BL = bilateral, NA = not available, ↓ or ↑= between 10- 
50ml/min outside normal expected QMRA values in the direction of the arrow, ↓↓ or ↑↑ = 
greater than 50ml/min beyond the normal expected QMRA values in the direction of the 
arrows, GKR = gamma knife radiosurgery, CAS = carotid angioplasty and stinting, Sx. = 
symptomatic. 
4. Case illustrations  
4.1 Case 1 
The patient is a 39-year-old otherwise healthy woman who presented five years previously 
with headaches and was found to have a right medial temporal arteriovenous malformation. 
She was offered intervention at that time, including surgical excision, but because of the 
quoted risks of the procedure the patient declined. She more recently presented to medical 
attention when she developed an acute onset headache associated with nausea and 
lightheadedness. CT scan of the brain showed a small subarachnoid hemorrhage adjacent to 
the AVM. Angiography showed the lesion to be fed primarily from enlarged branches of the 
posterior communicating artery and posterior cerebral artery. Venous egress was deep to an 
enlarged basal vein of Rosenthal and then to a dominant right transverse sinus (TS) (Figure 
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1A). NOVA analysis showed increased flow in the carotid artery and posterior cerebral 
artery on the side of the lesion with high flow in the draining basal vein of Rosenthal and 
the right TS relative to the left (Figure 1B-E).  
After consideration of different treatment strategies, the patient was treated with gamma 
knife radiosurgery. Six months later, the MRI appearance was without change. NOVA 
analysis, however, showed a decrease in the flow through the carotid artery on the right as 
well as a decrease in the flow through the right TS and draining basal vein (Figure 1F-G). 
 
Fig. 1. Case 1 Images: A, Lateral angiogram, right internal carotid injection (postero-anterior 
view) shows a medio-temporal AVM nidus fed by the posterior communicator, its 
perforators and the posterior cerebral artery and its perforators and draining through the 
basal vein of Rosenthal to the deep venous system and ultimately to the transverse sinus. B, 
C, NOVA 3D surface rendering shows the AVM nidus with the yellow cursor 
demonstrating where the flow was measured in the right transverse sinus (B) and basal vein 
of Rosenthal (C). D,E, NOVA baseline table (D) and vessel map (E) pre-radiosurgery 
demonstrates abnormally increased flow in the right posterior cerebral artery (PCA) and 
internal carotid artery (ICA) with marked asymmetry of flow in the right transverse sinus 
compared with the left. Flow in the basal vein is denoted “AVM” and is also quantitated. F, 
G NOVA baseline table (F) and vessel map (G) six months post-radiosurgery shows marked 
decreased in flow in the basilar, right ICA, basal vein of Rosenthal and transverse sinus. 
4.2 Case 2 
This 62-year-old man presented to an outside facility with the acute onset of a right 
hemiparesis, affecting the arm more than the leg, and accompanied by slurred speech. MRI  
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Fig. 2. Case 2 Images: A, Flair sequence MRI, axial section, shows a left hemisphere infarct. 
B, C, Lateral (B) and posterior-anterior (C) left vertebral angiogram shows reconstitution of 
the occluded left common carotid artery via cervicomuscular collaterals. D, CT perfusion 
scan after acetazolamide administration demonstrates decreased perfusion in the left MCA 
distribution. E, F, Pre-bypass NOVA 3D surface rendering shows absence of the left carotid 
artery in the cervical region and poor intracranial flow. G,H, Pre-bypass NOVA vessel map 
(G) and baseline table (H) show markedly abnormal flow in the left MCA and no flow in the 
left carotid artery. I, Coronal CTA after subclavian to carotid bulb bypass clearly 
demonstrates bypass patency. J, NOVA 3D rendering post-bypass shows the bypass with 
the cursor placed to measure flow. K, L, Post-bypass NOVA baseline table (K) and vessel 
map (L) demonstrate increased flow in the left MCA post-bypass, which is now in the 
normal range. 
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revealed an acute stroke in the left corona radiata consistent with a watershed infarction 
(Figure 2A). Further workup, including angiography, revealed an acute left common carotid 
occlusion with reconstitution of the carotid artery in the region of the carotid bulb via 
vertebral artery collaterals (Figure 2B,C). The patient was discharged home after near 
complete resolution of his hemiparesis and was referred for further evaluation because of 
the known carotid occlusion and daily recurrent episodes of visual loss in the left eye. 
CT perfusion with acetazolamide challenge showed a persistent deficit in the left MCA 
territory (Figure 2D) and fundoscopy revealed optic neuropathy consistent with a chronic 
low-flow state. NOVA analysis showed decreased flow in the left MCA and no flow in the 
left common carotid (Figure 2E-H). The patient underwent a subclavian to common carotid 
bypass (Figure 2I). The patient’s visual symptoms immediately resolved. Post-bypass 
NOVA showed good replacement flow in the bypass itself, good flow in the left ICA and 
normalization of flow in the left MCA (Figure 2J-L). 
4.3 Case 3 
This 52-year-old man with a history of hypertension, diabetes, hypercholesterolemia, 
coronary artery disease, and tobacco use had been placed on clopidogrel and aspirin after 
having multiple episodes of diplopia associated with hemisensory symptoms without 
infarct seen on MRI. After one such episode, imaging revealed bilateral occipital lobe, left 
cerebellar and right pontine acute infarctions (Figure 3A,B). Workup including CTA of the 
aortic arch, head and neck revealed multiple areas of irregular stenoses in the bilateral 
extracranial vertebral arteries. NOVA revealed diminished flow in both vertebral arteries 
with severely reduced flow in the left vertebral artery and basilar artery (Figure 3C).  
Under general anesthesia, the patient underwent diagnostic angiography which confirmed 
the multiple irregular stenoses in the vertebral arteries and sluggish flow into the basilar 
artery and its distal branches (Figure 3D-E). The patient underwent balloon angioplasty of 
the left extracranial vertebral artery at the C1 level, the area felt to harbor the most severely 
stenotic and irregular segment. Balloon angioplasty was performed using the recently FDA-
approved non-compliant Gateway balloon (Boston Scientific, Target) and was followed by 
placement of two telescoping recently FDA-approved WingSpan (Boston Scientific, Target) 
stents. This resulted in excellent angiographic dilatation with marked increased flow into 
the basilar artery and its tributaries (Figure 3F). This was confirmed by post-procedure 
NOVA (Figure 3G). The patient was discharged on clopidogrel and aspirin and did well 
with one readmission four months later for transient left facial numbness not associated 
with infarction. CTA performed at that time failed to reveal in-stent stenosis and MRI did 
not show an acute infarct and the patient was discharged home (Brisman, 2008). 
4.4 Case 4 
This 69 year old gentleman has a history of hypertension, hyperlipidemia and diabetes and 
three months prior to the current admission had an episode of vertigo and was found to 
have a right cerebellar and very small left cerebellar acute infarction (Fig. 4A). He made a 
good recovery and was discharged on clopidogrel. He was readmitted with episodes of 
diplopia and feeling unbalanced while walking. MRI showed bilateral cerebellar and 
occipital lobe small acute infarctions. CTA revealed a very focal area of vertebral artery  
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Fig. 3. Case 3 Images: A: Diffusion-weighted brain MRI showing acute left cerebellar 
hemisphere infarction. B: QMRA (NOVA) flow map showing markedly diminished flow in 
both vertebral arteries (26 and 58 cc/min) and in the basilar (5 cc/min). R = right; L = left; 
MCA = middle cerebral artery; ACA = anterior cerebral artery; CCA = common carotid 
artery; ICA = internal carotid artery; BA = basilar artery and VA = vertebral artery. 
Directionality of blood flow is also given (arrows). C: QMRA (NOVA) flow table giving the 
values seen in the flow map with the “range” column representing expected normal values. 
D: Right subclavian artery angiogram, postero-anterior view, demonstrates severe right 
vertebral origin stenosis. E: Magnified oblique view of the left vertebral artery angiogram 
demonstrating stenotic irregular plaque in the high cervical vertebral artery. F: Successful 
angiographic reconstruction post-stent placement is seen on this left vertebral artery 
angiogram, oblique view. G: Cervical spine lateral x-ray demonstrates the two telescoping 
WingSpan stents placed at the C1 level of the vertebral artery. H: QMRA (NOVA) flow table 
demonstrating the marked increase in the left vertebral artery flow after stenting with 
resultant increase in basilar flow. 
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Fig. 4. Case 4 Images: A: Diffusion-weighted brain MRI showing acute right cerebellar 
medial hemispheric infarction. B: NOVA MRA shows the region on the basilar artery 
(yellow line) where the flow was measured. Flow is normal (157 ml/min). C: QMRA 
(NOVA) flow map shows very low flow in the right vertebral artery (26 ml/min) compared 
with the non-stenotic left vertebral artery (164 ml/min). Again, normal flow in the basilar 
artery is seen. Abbreviations as defined in figure 2. D: Right vertebral artery postero-anterior 
angiogram demonstrates severe right vertebral stenosis proximal to its entrance 
intracranially. E:  Right vertebral artery angiogram, lateral view, again demonstrates the 
stenotic lesion. F: Right vertebral artery angiogram, magnified lateral view, shows good 
angiographic result post-angioplasty and stent placement. G: QMRA (NOVA) flow map 
shows increased flow in the right vertebral artery post-stenting. H: QMRA (NOVA) flow 
table demonstrates that the flow in the right vertebral artery post-stenting approaches the 
expected normal values.  
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stenosis a small distance prior to its entrance into the foramen magnum. QMRA showed 
markedly diminished flow in the right vertebral artery compared with the left with normal 
basilar flow (Fig. 4B,C). The patient was taken for diagnostic angiography which confirmed 
one single very severe stenosis just proximal to the entrance of the vertebral artery into the 
posterior fossa (Fig. 4D,E). 
Under full heparinization, a 6 French Envoy was navigated into the right vertebral artery 
and the Gateway balloon measuring 3.5mm X 15mm was used to perform angioplasty of the 
stenotic segment. Using the same 0.14 microguidewire for support, a WingSpan stent 
measuring 3mm X 15mm was deployed across the stenosis with good angiographic result 
(Fig. 4F). The QMRA documented increased flow in the right vertebral artery (Fig. 4G,H). 
The patient has remained symptom-free at the five-month follow-up (Brisman, 2008). 
4.5 Case 5 
This 36-year-old woman with history of migraine headaches was evaluated by a vascular 
surgeon for MRA findings suggestive of fibromuscular dysplasia (FMD). She was treated 
conservatively until she had two episodes of left hand incoordination over several months 
followed by several more episodes of left hand numbness and tingling. The attacks were 
often associated with anxiety and sometimes headaches and the diagnoses of complicated 
migraine and seizures were entertained. Her EEG did not suggest seizure activity and the 
episodes continued despite anticonvulsants. 
Her MRA showed moderate right internal carotid stenosis over a long segment and mild left 
internal carotid stenosis with an associated kinking and small pseudoaneurysm (Figure 5A). 
NOVA showed significantly reduced flow in the internal carotid artery on the right with 
normal flow in the internal carotid artery on the left (Figure 4B). Formal angiography 
confirmed this (Figure 5C). She underwent right internal carotid artery angioplasty with 
good angiographic result (Figure 5D) and has not had further symptoms. NOVA post-
procedure confirmed increased flow in the RICA (Figure 5E,F). 
5. Discussion 
The main finding of this chapter’s research is that the NOVA commercially available 
software was used in a variety of different cerebrovascular disease processes and found to 
accurately represent the diagnosed pathophysiology and to reflect the expected changes of a 
therapeutic intervention. Excessive unexplained values outside of the company’s quoted 
normal ranges render interpretation in a given study difficult and limit its utility at present. 
Since this study was completed, the company has issued more specific and hopefully more 
accurate normal control values based on their research suggesting alteration of expected 
normal values in different age populations. This study expands on a recently published 
study involving a subset of the current cohort in which arterial waveform analysis was 
shown to correlate with a neurovascular intervention (Brisman et al., 2011) We look forward 
to further evaluation of this technology using these new baselines. Although there are 
currently several good imaging modalities with which to study the cervico-cerebral 
vasculature (including ultrasound, CTA, MRA), these tests yield static images at one point 
in time. Catheter-based angiography can offer additional information about pace of blood 
flow and collateralization, but because of the invasiveness of the procedure there continues  
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Fig. 5. Case 5 Images: A, MRA of the cervical vasculature demonstrates a right internal 
carotid long segment narrowing with a focal area of severe stenosis as well as a left internal 
carotid artery kink with an associated aneurysm in this patient with presumed FMD. B, Pre-
angioplasty NOVA vessel map documents marked decrease in flow in the right internal 
carotid artery. C, Right common carotid angiogram, oblique view, pre-angioplasty (C) and 
post-angioplasty (D) shows excellent revascularization. E, NOVA 3D surface rendering of 
the cervical vasculature post-angioplasty appears strikingly similar to the angiogram in D. F, 
NOVA vessel map post-angioplasty documents marked increase in flow in the right internal 
carotid artery.  
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to be a search for less invasive modalities that can give similar or better information. 
Techniques such as SPECT, Xenon-CT, TCD, PET, CT Perfusion, and MR Perfusion offer an 
assessment of cerebrovascular physiology, but do not give quantitative information of blood 
flow in specific vessels. NOVA represents the only commercially available method to 
quantify cervico-cerebral blood flow utilizing standard MRI platforms.  
5.1 NOVA in specific disease entities 
5.1.1 Radiosurgery of brain AVMs 
This represents the first demonstration of QMRA for brain AVMs as well as the first 
demonstration of QMRA changes after radiosurgery in brain AVMs. Prior attempts to 
noninvasively measure blood flow in vascular malformations have been restricted to the use 
of ultrasound. In one study NOVA was used to demonstrate the efficacy of endovascular 
embolization of Vein of Galen Malformations (Langer et al., 2006b). In the two reported 
cases NOVA performed before and after embolization documented marked decrease in 
blood flow in draining veins that correlated with angiographic findings.  
In the current report, two out of three patients with brain AVMs demonstrated marked 
increased flow in the main arterial inputs to the malformation with asymmetric increased 
blood flow in the transverse sinus system receiving the AVM venous drainage. Currently 
NOVA offers no baseline values for blood flow in the dural venous sinuses. Therefore, the 
interpretation of changes in blood flow in the venous sinus system six months after 
radiosurgery is based on relative and not absolute values and is of unclear significance. 
Clear decreases in blood flow in all three cases in the draining sinuses, more pronounced 
on the side of the AVM in the two non-midline lesions, was used to counsel these patients 
that despite no change in the AVM appearance on routine brain MRI, that the 
radiosurgery may be having an effect as evidenced by decreased blood flow in the venous 
drainage. 
5.1.2 Fibromuscular dysplasia and carotid stenosis 
This represents the first study documenting NOVA flow measurements in two patients with 
FMD and carotid stenosis (CS) and the first to demonstrate changes in NOVA after carotid 
angioplasty in one affected patient. Ghogawala et al. (2008) demonstrated increased flow 
following carotid endarterectomy in a patient with carotid stenosis using NOVA. They also 
showed that diminished blood flow from carotid stenosis correlated with improved 
cognitive outcomes after revascularization and suggested that quantification of blood flow 
before and after revascularization using NOVA may be an important way to study the 
effects of the intervention (Brisman, 2008). While CS secondary to atherosclerotic disease has 
been well studied, carotid steno-occlusive disease in patients with fibromuscular dysplasia 
is a less familiar entity. Whereas CS from atherosclerosis is felt to cause symptoms from 
thrombo-embolism, this is not the case with FMD, where decreased flow may play more of a 
role. This probably reflects the different histologic pathology between the two diseases. As a 
result, treatment options for patients with CS and FMD have been more controversial, 
reflecting our lack of understanding of the natural history risks as well as the treatment risk 
of either open or endovascular options. 
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Various open surgical treatments have been used historically for CS in patients with FMD, 
ranging from surgical exposure and angioplasty under direct vision to excision of the 
diseased segment and patching. Currently, endovascular angioplasty is the most popular 
treatment for symptomatic CS in FMD patients and its success parallels that in the renal 
vasculature of such patients. FMD patients with asymptomatic CS represent a group in 
which no clear recommendations exist. In cases of moderate to severe stenosis, NOVA may 
provide the best way to follow such patients. At what point to intervene based on changes 
in NOVA flow remains an unanswered question. Based on our two cases, NOVA 
documented clearly decreased flow with marked increase after angioplasty in the one 
patient treated.  
5.1.3 Vasospasm after SAH 
Cerebral vasospasm after aneurysmal subarachnoid hemorrhage remains the most 
significant source of morbidity and mortality in these patients, with an estimated one sixth 
of all patients developing permanent disability. While the exact etiology and 
pathophysiology of the process is unknown, screening and detection using transcranial 
dopplers, computed tomographic angiography and catheter angiography are well described 
and important as treatment options that may avert stroke are available. 
By quantifying blood flow in spastic vessels, NOVA may be a better method with which to 
detect and follow vasospasm as well as assess instituted therapies. Transcranial doppler 
ultrasonography and CTA yield anatomic information only and are therefore poor 
predictors of who will develop symptomatic vasospasm. Angiography is somewhat 
invasive, is impractical to perform multiple times during the vasospasm period and also 
generates mostly anatomic information.  
NOVA appeared to correlate with CTA and angiography in the one patient studied. This is 
the first demonstration of vasospasm using NOVA. A modified abridged version of the 
NOVA was performed on this patient in which only three vessels were studied: the basilar 
artery and both MCA arteries. The intent was to reduce the time required for the test (to 
under 10 minutes) such that it would be practical for critically ill patients such as those who 
have suffered subarachnoid hemorrhage and may have vasospasm. Additionally it made 
sense to study only these vessels as it is only in these vessels that balloon angioplasty is 
generally performed in cases of medically refractory vasospasm. Further studies evaluating 
larger numbers of patients and looking at additional vessels, particularly the anterior 
cerebral and supraclinoid carotid arteries, might also be important. 
5.1.4 Vascular bypass for ischemia 
NOVA was used to study two patients who underwent extracranial-intracranial bypass as 
part of a cerebrovascular augmentation procedure in the setting of unilateral carotid 
occlusion, ipsilateral symptoms and documented poor cerebrovascular reserve. The use of 
NOVA to study the integrity and potential utility of bypass for occlusive ischemic disease 
has been previously studied by Amin-Hanjani et al. when they reviewed 101 bypasses in 
which they performed NOVA before and after. They showed that NOVA was a good way to 
document the integrity of the graft and to follow it over time (Amin-Hanjani et al., 2007).  
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In our patient with a subclavian-carotid bypass, NOVA readily measured flow in the graft 
and documented increased intracranial flow compared to the patient’s presurgical state. 
In the patient with the STA-MCA bypass, despite patency on angiographic imaging, 
NOVA could not measure flow in the graft, suggesting that the flow was too low to be 
detected or technical error of the NOVA. NOVA requires a certain size vessel to obtain 
measurements. As the graft matures, future NOVA studies may be able to detect and 
measure flow. 
5.1.5 Atherosclerotic disease and endovascular revascularization 
NOVA was used in four patients with vertebrobasilar ischemia, two from severe basilar 
artery stenosis and two from extradural vertebral stenosis. In three out of four patients, the 
authors considered NOVA to be CD. One of the patients with vertebral disease had a 
solitary focus and the other had multiple lesions. In the two patients with basilar stenosis 
and very low flow in the basilar artery (cases 3 and 4), results of NOVA were used to 
recommend balloon angioplasty and stent placement despite the patients not having failed 
maximal medical therapy. The justification for this was based on the results of one study 
that used NOVA flow in the basilar and posterior cerebral arteries to predict which patients 
with vertebrobasilar ischemia would benefit from posterior circulation revascularization as 
opposed to medical therapy (Amin-Hanjani et al., 2005). Both patients declined 
interventional treatment. 
Cases 3 and 4 document the utilization of the new WingSpan stent and Gateway balloon 
system to treat two patients with medically refractory vertebrobasilar ischemia secondary to 
cervical vertebral artery stenosis. The self-expanding nitinol stent is designed for use after 
balloon angioplasty using a specially designed balloon and has not been previously 
described in the treatment of extracranial vertebral artery disease (Brisman, 2008). 
This is the first description of the use of this novel stent for the treatment of the extracranial 
vertebral arteries as well as the first documentation of QMRA before and after WingSpan 
stenting of any vessel (Brisman, 2008). 
Historically, extracranial vertebral artery disease had been treated with surgical bypass 
(Spetzler et al., 1987) but has since given way to endovascular approaches. This shift reflects 
the technical difficulty and unfamiliarity of most neurosurgeons with the former and the 
improved success and experience with the latter. Stenting and angioplasty has been well 
described for the extracranial vertebral arteries (Ko et al., 2004 & Malek et al., 1999) with 
some success with both balloon-mounted coronary stents and self-expanding stents 
designed for non-cerebral revascularization. Such stents can be difficult to navigate due to 
the tortuosity of the cervico-cerebral vasculature and associated with complication rates 
(4.8% major morbidity in one series) (Malek et al., 1999) that may relate to the difficulty with 
stent delivery, overly aggressive balloon angioplasty and/or excessive radial force during 
deployment or afterwards. Recurrent events post-stenting (persistent in 9.5% in one series) 
(Malek et al., 1999) and high rates of restenosis (10-43%) (Ko et al., 2004) suggest that current 
endovascular options may be improved upon. The WingSpan stent system and Gateway 
balloon were specifically designed to access and treat more fragile intracranial vessels. The 
seminal safety study of this stent used in 45 patients with medically refractory intracranial 
stenosis was recently published (Bose et al., 2007). Although not specifically designed for 
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extracranial disease, the system was employed with technical ease and success in the two 
patients here described. 
In addition to this technical success associated with very acceptable angiographic results, 
QMRA demonstrated expected increases in flow in the treated vertebral artery in both 
patients. That said, one patient did have an episode several months later of transient facial 
numbness that may have represented a posterior circulation transient ischemic attack. This 
patient, however, has multiple risk factors for vasculopathic disease and stenting was 
directed to the most stenotic and irregular region of the vertebral artery. If such episodes 
persist, consideration may be given to treatment of his additional vertebral stenoses. 
Another caveat of this system is the issue of in-stent restenosis, which has been well 
described for vertebral artery stents, and which was not addressed in this report. As the 
clinical follow-up is short and no catheter angiographic follow-up has been presented, the 
durability of the WingSpan stent in the extracranial vertebral arteries remains unknown. 
QMRA may prove useful to follow such patients post-stenting as decreased flows may 
herald restenosis. 
Currently there are several very good imaging modalities with which to study the 
anatomy of the cervico-cerebral vasculature. These include ultrasound (carotid duplex 
and transcranial duplex), CTA, MRA and catheter angiography and range from non-
invasive (duplex, MRA) to minimally invasive (CTA) to invasive with low risk (catheter 
angiography). Those studies that are minimally or non-invasive, however, yield static 
images, and despite tremendous advances in the ability to manipulate these images, the 
studies do not give more than a picture of the vascular anatomy at one point in time. 
Catheter angiography offers specific additional information about cervico-cerebral 
vascular pathology such as pace of blood flow and collateralization. Because of the 
invasiveness of the procedure, however, there has been a continued search for less 
invasive modalities that might offer similar or better information. Additional modalities 
have been developed, therefore, using a wide range of techniques, that attempt to give 
some assessment of cerebrovascular physiology. Such techniques include SPECT, Xenon-
CT, TCD, PET, CT Perfusion, and MR Perfusion. None of these studies gives quantitative 
information of blood flow. NOVA is a software package that represents the only 
commercially available technique to quantify cervico-cerebral blood flow utilizing 
standard MRI platforms. It has been shown to effectively risk-stratify patients with 
vertebrobasilar ischemia based on distal flow in the basilar and posterior cerebral arteries 
(Amin-Hanjani et al., 2005). 
In these two cases, vessel dilatation post-procedure was associated with an expected 
increase in flow values. Interestingly, in one of the two cases, basilar flow was normal, 
suggesting the lesion was not flow-limiting. Stent placement in that patient might have 
more efficacy as an intimal stabilizer against further thrombo-embolic events, whereas in the 
other patient flow-limitation and thrombo-embolism were both probably contributing to 
ischemia (Brisman, 2008). 
5.2 Caveats to this study and limitations of NOVA 
Some of the findings of this study are objective, such as the common occurrence of abnormal 
values that lacks a simple explanation. Our study surprisingly showed a 41% false positive 
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rate, bringing into question the validity of the software. It is possible, however, that we did 
not appreciate that the abnormal flow in a given vessel was part of the pathologic process. 
Additionally, it is possible that the defined “normal values” from the company need 
adjustment. The more subjective part of this report involves the designation of HP, CD or 
NUD to a given NOVA test. This designation is multifactorial and incorporates our 
understanding of the disease process, the kinds of patients evaluated and referred for 
NOVA testing and threshold for intervention.  
There are quite a few limitations of the NOVA technology, some of which likely are 
preventing its adoption into mainstream cerebrovascular care. The most prominent 
problem is the lack of properly defined baseline normal values, as mentioned above. The 
baseline values provided by the company are based on a large cohort of healthy 
volunteers. The company is currently studying another large group of volunteers in an 
effort to better define baseline values (personal communication). Particular clarification is 
needed with regard to defining the range of normal values and what, if any, adjustments 
should be made for certain patient-specific factors such as age (which has recently been 
addressed), cardiac dysfunction or dehydration, to name just a few. Is there a range of 
fluctuation in NOVA values that is acceptable for a given individual at different periods 
of the day or seasonally? Do NOVA results vary in relation to meals or with patients who 
are febrile, diabetics or smokers? All these questions will need to be answered in order to 
make the appropriate adjustments such that true pathologic states can be ascertained 
across a wide spectrum of patients. These caveats not withstanding, we do believe that the 
findings here of alteration in flow in an expected manner for those patients undergoing an 
intervention is significant but agree that further validation of the basic software is in 
order. 
6. Conclusion 
NOVA represents the only currently available method to non-invasively quantify blood 
flow in the human cervico-cerebral vasculature and will likely play a more prominent role 
in cerebrovascular care as research better defines expected values for different patient 
populations at baseline and in disease states. This study represents the largest clinical 
experience using NOVA in a routine cerebrovascular practice encompassing diverse 
pathologies. Analyses of NOVA in certain conditions, such as radiosurgery of brain AVMs, 
carotid stenosis from fibromuscular dysplasia, and vasospasm after aneurysmal 
subarachnoid hemorrhage have not been previously described. We found NOVA to 
accurately reflect expected blood flow changes before and after a neurovascular intervention 
in all cases. Further research into this new technology that better defines expected normal 
and disease state values will likely result in increased incorporation into mainstream 
cerebrovascular practice.  
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